Adrenomedullin, an Endogenous Peptide, Counteracts Cardiovascular Damage
- 1 January 2002
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 105 (1) , 106-111
- https://doi.org/10.1161/hc0102.101399
Abstract
Background— Adrenomedullin (AM), a potent vasodilator peptide, is produced by posttranslational splicing of pro-adrenomedullin together with proadrenomedullin N-terminal 20 peptide (PAMP), another ...Keywords
This publication has 20 references indexed in Scilit:
- Understanding hypertension through genetic manipulation in miceKidney International, 2000
- Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaningNature Genetics, 1997
- Genomic Organization, Expression, and Chromosomal Mapping of the Mouse Adrenomedullin GeneGenomics, 1996
- Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.Journal of Clinical Investigation, 1996
- Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cellsJournal Of Hypertension, 1996
- Proadrenomedullin NH(2)-terminal 20 peptide, a new product of the adrenomedullin gene, inhibits norepinephrine overflow from nerve endings.Journal of Clinical Investigation, 1995
- Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasmaFEBS Letters, 1994
- Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide (PAMP)FEBS Letters, 1994
- Cloning and Characterization of cDNA Encoding a Precursor for Human AdrenomedullinBiochemical and Biophysical Research Communications, 1993
- Adrenomedullin: A Novel Hypotensive Peptide Isolated from Human PheochromocytomaBiochemical and Biophysical Research Communications, 1993